What is the difference between Augmentin (amoxicillin-clavulanate) and amoxicillin for the treatment of otitis media (OM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin vs Amoxicillin for Otitis Media Treatment

High-dose amoxicillin should be used as first-line treatment for most cases of acute otitis media (AOM), while Augmentin (amoxicillin-clavulanate) should be reserved for specific situations where beta-lactamase-producing organisms are likely present. 1

Key Differences Between Augmentin and Amoxicillin

Antimicrobial Coverage

  • Amoxicillin:

    • Effective against susceptible and intermediately resistant Streptococcus pneumoniae (83-87% of isolates)
    • Limited activity against beta-lactamase-producing organisms
    • Recommended dosage: 80-90 mg/kg/day in 2 divided doses 1
  • Augmentin (amoxicillin-clavulanate):

    • Contains clavulanic acid, a beta-lactamase inhibitor
    • Effective against S. pneumoniae AND beta-lactamase-producing H. influenzae and M. catarrhalis
    • Recommended dosage: 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate in 2 divided doses 1, 2

Clinical Decision Algorithm for AOM Treatment

First-Line Treatment (Standard Cases)

  • High-dose amoxicillin (80-90 mg/kg/day in 2 divided doses) for:
    • Uncomplicated first episode of AOM
    • No recent antibiotic use
    • No concurrent conjunctivitis
    • No risk factors for resistant organisms 1

When to Use Augmentin Instead

Use high-dose amoxicillin-clavulanate when:

  1. Patient has taken amoxicillin in the previous 30 days
  2. Concurrent purulent conjunctivitis is present (strongly suggests H. influenzae)
  3. Treatment failure with amoxicillin after 48-72 hours
  4. Recurrent or persistent AOM
  5. Coverage for M. catarrhalis is specifically desired 1

Efficacy Considerations

Hoberman et al. demonstrated superior efficacy of high-dose amoxicillin-clavulanate in eradicating S. pneumoniae (96%) from the middle ear compared to azithromycin 1. Another study showed that amoxicillin-clavulanate eradicated 96% of S. pneumoniae (including 92% of fully penicillin-resistant strains) and 89.7% of H. influenzae 3.

Side Effect Profile

  • Amoxicillin: Generally well-tolerated with fewer gastrointestinal side effects
  • Augmentin: Higher incidence of diarrhea due to clavulanate component 1, 4
    • A study showed 26% of children on standard Augmentin developed protocol-defined diarrhea 4
    • Newer formulations with reduced clavulanate concentrations may cause less diarrhea while maintaining efficacy 4

Common Pitfalls to Avoid

  1. Overuse of Augmentin: Using Augmentin as first-line therapy for all AOM cases increases side effects without providing additional benefit in uncomplicated cases

  2. Underdosing amoxicillin: Using standard-dose rather than high-dose amoxicillin may lead to treatment failure with intermediately resistant S. pneumoniae

  3. Failing to switch to Augmentin when indicated: Not changing to amoxicillin-clavulanate after amoxicillin failure within 48-72 hours 1

  4. Ignoring risk factors for resistant organisms: Recent antibiotic use, daycare attendance, and winter season increase risk of resistant pathogens

Treatment Duration

  • Children <2 years: 10 days
  • Children ≥2 years with mild/moderate illness: 5-7 days 1

In conclusion, while both medications are effective for treating AOM, high-dose amoxicillin remains the first-line treatment for most cases due to its efficacy, safety, low cost, and narrower antimicrobial spectrum. Augmentin should be reserved for specific situations where beta-lactamase-producing organisms are suspected or when initial amoxicillin treatment fails.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.